The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia
Authors:
- Celine M. RadderCRCeline M. Radder
- Dave L. RoelenDRDave L. Roelen
- Ellen M.W. van de Meer-PrinsEMEllen M.W. van de Meer-Prins
- Frans H.J. ClaasFCFrans H.J. Claas
- Humphrey H.H. KanhaiHKHumphrey H.H. Kanhai
- Anneke BrandABAnneke Brand
- 1 September 2004
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 191 (3) , 815-820
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopeniaAmerican Journal of Obstetrics and Gynecology, 2001
- Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individualsClinical and Experimental Immunology, 2001
- Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord bloodAmerican Journal of Obstetrics and Gynecology, 2000
- Quantitative Analysis of Leukocyte Membrane Antigen Expression on Human Fetal and Cord Blood: Normal Values and Changes during DevelopmentClinical Immunology and Immunopathology, 1997
- Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapyThe Journal of Pediatrics, 1997
- Manipulating the Immune System with Immune GlobulinNew England Journal of Medicine, 1992
- Quantitative analysis of T and B cell subsets in healthy and sick premature infantsEarly Human Development, 1991